Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2003 1
2004 1
2005 1
2006 1
2007 8
2008 1
2009 2
2010 2
2011 2
2013 1
2014 1
2015 2
2017 3
2018 2
2019 2
2020 5
2021 6
2022 5
2023 1
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

46 results

Results by year

Filters applied: . Clear all
Page 1
A National Registry for People With All Stages of Kidney Disease: The National Kidney Foundation (NKF) Patient Network.
Inker LA, Ferrè S, Baliker M, Barr A, Bonebrake L, Chang AR, Chaudhari J, Cooper K, Diamantidis CJ, Forfang D, Gillespie B, Gregoriou P, Gwadry-Sridhar F, Ladin K, Maxwell C, Mitchell KR, Murphy KP, Rakibuz-Zaman M, Rocco MV, Spry LA, Sharma A, Tangri N, Warfield C, Willis K; NKF Patient Network Governance Committees. Inker LA, et al. Among authors: gillespie b. Am J Kidney Dis. 2023 Feb;81(2):210-221.e1. doi: 10.1053/j.ajkd.2022.07.016. Epub 2022 Sep 30. Am J Kidney Dis. 2023. PMID: 36191726
Clinical Trial Considerations in Developing Treatments for Early Stages of Common, Chronic Kidney Diseases: A Scientific Workshop Cosponsored by the National Kidney Foundation and the US Food and Drug Administration.
Inker LA, Grams ME, Guðmundsdóttir H, McEwan P, Friedman R, Thompson A, Weiner DE, Willis K, Heerspink HJL; NKF-FDA Conference on Clinical Trial Considerations in Developing Treatments for Early Stages of Common, Chronic Kidney Diseases Advisory Group. Inker LA, et al. Am J Kidney Dis. 2022 Oct;80(4):513-526. doi: 10.1053/j.ajkd.2022.03.011. Epub 2022 Aug 13. Am J Kidney Dis. 2022. PMID: 35970679
Innovating and invigorating the clinical trial infrastructure for glomerular diseases.
Barisoni L, Barratt J, Campbell K, Eva L, Gillespie BS, Gipson D, Huber T, Jardine M, Kamil E, Kretzler M, Lee L, Levtchenk E, Mehr AP, Nachman PH, Oh J, Saleem M, Shankland SJ, Smith K, Smokler I, Smoyer W, Tarnoff J, Thompson A, Trachtman H, Udani S, Vivarelli M, Walker P, West M, Rovin BH. Barisoni L, et al. Among authors: gillespie bs. Kidney Int. 2021 Mar;99(3):519-523. doi: 10.1016/j.kint.2020.09.038. Kidney Int. 2021. PMID: 33637197 No abstract available.
46 results